NCT03345355

Brief Summary

The investigators hypothesize that the T1 Dixon post-Gadolinium and T2 Dixon sequences will show good diagnostic performances for active sacroiliitis compared to the reference test (Short tau inversion recovery) and clinical-biological criteria, which will allow a better diagnosis of active sacroiliitis

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 17, 2017

Completed
12 months until next milestone

Study Start

First participant enrolled

November 13, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

August 9, 2021

Status Verified

August 1, 2021

Enrollment Period

1.1 years

First QC Date

November 14, 2017

Last Update Submit

August 3, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic performance of T1 Dixon post-Gadolinium and T2 Dixon for active sacroiliitis, according to subchondral edema status

    compared to ASAS criteria incorporating Short tau inversion recovery and clinic-biological elements

    Time 0

Secondary Outcomes (4)

  • Diagnosis of enthesitis from T1 Gadolinium Dixon sequence vs ASAS criteria

    Time 0

  • Diagnosis of synovitis from T2 Dixon and T1 Gadolinium Dixon sequences vs ASAS criteria

    Time 0

  • Diagnosis of chronic sacroiliite (erosion or chondral scler osis, or fatty spinal replacement) by T1 Dixon pre-Gadolinium

    Time 0

  • Diagnosis of chronic sacroiliite (erosion or chondral sclerosis, or fatty spinal replacement) by conventional sequences

    Time 0

Study Arms (1)

patient with axial spondyloarthritis

Diagnostic Test: Imaging

Interventions

ImagingDIAGNOSTIC_TEST

Coronal oblique T1, Coronal oblique and axial STIR, Coronal oblique T1 Dixon, Coronal oblique and Axial T2 Dixon and T1 Dixon post Gadolinium

patient with axial spondyloarthritis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with clinically-confirmed axial spondyloarthritis treated in the radiology services of the CHUs of Montpellier and Nimes

You may qualify if:

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is at least 18 years old
  • The patient has a clinically diagnosed axial spondyloarthritis (axSpA) (ASAS or AMOR classification)
  • Patient has an active axSpA (BASDAI\>4)

You may not qualify if:

  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • The patient is pregnant or breastfeeding
  • The patient has a contra-indication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU Lapeyronie

Montpellier, 34090, France

Location

CHU Nimes

Nîmes, 30029, France

Location

MeSH Terms

Conditions

Spondylarthritis

Interventions

Diagnostic Imaging

Condition Hierarchy (Ancestors)

SpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesArthritisJoint Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2017

First Posted

November 17, 2017

Study Start

November 13, 2018

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

August 9, 2021

Record last verified: 2021-08

Locations